Corporate Capture of Regulation: Industry Self-Policing

Corporate Capture of Regulation: Industry Self-Policing

We have been tracking the slow creep of corporate influence into the mechanisms meant to protect the public. Across sectors from finance to pharmaceuticals we see patterns of revolving doors between regulators and industry. We draw on books such as George Monbiot's Captive State and Ben Goldacre's Bad Pharma, leaked troves like the Paradise Papers and reporting by ProPublica and The Guardian. Our aim is to map how self-policing emerges, what financial records and investigative journalists have uncovered, and where important questions remain unresolved.

Background: Why self-policing matters

We start from a simple premise. Regulators are meant to act as neutral guardians of the public interest. When industry designs the rules or monitors compliance the balance shifts. We see this in historical accounts of banking before 2008 and in the pharmaceutical sector where trial design and post market surveillance often lie in industry hands. Authors such as Bethany McLean and Joe Nocera in All the Devils Are Here and Ben Goldacre in Bad Pharma lay out the structural risks.

The revolving door and soft power

We have repeatedly found the same mechanism. Senior officials move into industry roles. Industry advisors take seats on regulatory boards. This revolving door creates shared language and loyalties. Data from transparency groups such as OpenSecrets in the United States and Transparency International in the United Kingdom demonstrates the scale of lobbying and personnel movement. Investigative teams at ProPublica and The Bureau of Investigative Journalism have documented specific instances where regulators later took industry-paid posts and vice versa.

Leaked documents and financial trails

Leaked datasets change the conversation from anecdote to evidence. The Panama Papers and Paradise Papers published by the International Consortium of Investigative Journalists revealed how corporate structures and offshore arrangements intersect with policy influence. Financial records and company filings often show sponsorship of research, funding of advisory panels and donations to think tanks that then produce supposedly independent policy recommendations. We do not claim personal credit for these documents. We rely on the reporting of ICIJ and investigative journalists.

Case studies and investigative reporting

There are well reported episodes that crystallise the problem. Banking regulation prior to the 2008 crash and subsequent inquiries reveal regulators working too closely with banks. The pharmaceutical industry has numerous examples where trials and safety monitoring were effectively outsourced to organisations paid by manufacturers. The Guardian and ProPublica have produced careful chronology and documentation. Books such as George Monbiot's Captive State argue that corporate influence is systemic rather than incidental.

Gaps, caveats and unresolved questions

We must be honest about limits. Not every instance of industry involvement proves capture. Some advisory input is necessary because of technical expertise. Leaked documents point to patterns but rarely offer incontrovertible proof of intent. We lack a single global dataset that quantifies the causal impact of capture across sectors. These are open questions that require more FOI work, more whistleblowers and more financial transparency.

Implications and what we can do

We believe that stronger conflict of interest rules, transparent funding disclosures and independent public funding for scientific research would reduce the scope for self-policing. We urge more investigative work and more public scrutiny. We cite investigative reporting and scholarship to inform our readers rather than to assign blame to specific individuals without full context.

References and sources are listed below for readers who want to dig deeper.

Sign up to our newsletter for daily briefs.

References and sources